
Nyheter
More information about Nyheter

Fabry disease
Fabry disease is an X-linked lysosomal storage disease due to a defect in the gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A), causing progressive cellular accumulation of the substrate globotriaosylceramide (GL-3) and globo-triaosylsphingosine (lyso-GL-3).

Cardiac involvement in Fabry disease
Cardiovascular disease is the leading cause of death in Fabry disease patients.1 Undiagnosed and untreated Fabry disease leads to progressive, irreversible, life-threatening heart injury.2,3

Renal involvement in Fabry disease
Think Fabry, think renal involvement that may present early in life and could go undetected.

When to treat
Think Fabry, think early treatment to help slow or prevent life-threatening disease progression.1,2

Atopic dermatitis pathophysiology: type 2 inflammation & cytokines
Beneath the skin of patients with AD—type 2 inflammation and the cytokines involved.
Leave site modal
Du er i ferd med å forlate campus.sanofi/no. Sanofi er ikke ansvarlig for innholdet på dette eksterne Nettstedet.
Jobber du innen helsevesenet?
Denne nettsiden inneholder informasjon som er kun for helsepersonell som lege, tannlege, offentlig godkjent sykepleier, farmasøyt, optiker, tannpleier, samt studenter i disse fag.